期刊文献+

应用血清蛋白质指纹图谱筛选类风湿关节炎的血清标志物 被引量:3

Identification of serum biomarkers for rheumatoid arthritis using protein fingerprint
原文传递
导出
摘要 目的用表面增强激光解吸电离飞行时间质谱(SELDI-TOF-MS)和蛋白质芯片技术检测类风湿关节炎(RA)患者血清蛋白质指纹图谱,探讨基于人工神经网络的蛋白质指纹图谱模型对RA血清诊断标志物的筛选。方法用H4蛋白芯片结合SELDI-TOF-MS测定了141例血清标本的蛋白质指纹图谱,其中RA 90例,系统性红斑狼疮(SLE)20例,健康志愿者31名。将筛选出的血清蛋白质指纹图谱作为输入,建立人工神经网络预测模型,用随机抽取的93例标本(RA 60例,SLE 13例,健康志愿者20名)作为训练组,进行训练与交叉验证,并用另外测试组48例(RA 30例,SLE 7例,健康志愿者11名)的血清标本盲法验证该模型,同时与抗环瓜氨酸肽(抗CCP)抗体检测结果进行比较。结果利用从训练组得出的基于人工神经网络的血清蛋白质指纹图谱模型,对测试组的48例未知血清进行预测,结果显示,对RA检测的敏感性为90%(27/30),特异性为90.9%(9/11),阳性率为90.2%(37/41),明显高于抗CCP抗体检测结果。结论血清蛋白质指纹图谱可有效筛选RA血清中特异性蛋白标志物,基于人工神经网络的血清蛋白质质谱模型较以往传统方法具有更高的敏感性和特异性。 Objective To identify serum biomarkers for rheumatoid arthritis (RA) by protein fingerprint pattern. Methods One hundred and forty-one serum samples of 90 RA patients, 20 systemic lupus erythematosus (SLE) patients, and 31 healthy individuals were randomly divided into training set (n=93, 60 RA patients, 13 SLE patients and 20 healthy individuals) and test set (n=48, 30 RA patients, 7 SLE patients and 11 healthy individuals). They were detected by surface enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS). The protein fingerprint pattern obtained from SELDI-TOF was trained by a multi-layer artificial neural network (ANN) to establish a diagnostic model. Results The detective model obtained by ANN was used to detect the 48 unknown serum samples. The sensitivity and specificity for RA detection was 90% and 90.9% respectively. Conclusion In comparison with traditional methods, SELDI- TOF-MS could identify new serum biomarkers in RA. Combined with ANN, it provides high sensitivity and specificity for RA diagnosis.
出处 《中华风湿病学杂志》 CAS CSCD 2007年第6期344-347,共4页 Chinese Journal of Rheumatology
基金 山东省科技厅基金(YZ001C16)
关键词 关节炎 类风湿 生物学标记 蛋白质指纹图谱 人工神经网络 Arthritis, rheumatoid Biological markers Proteomics Artificial neural network
  • 相关文献

参考文献1

二级参考文献38

  • 1Koike A, Takagi T. Prediction of protein-protein interaction sites using support vector machines. Protein Eng Des Sel 2004;17:165-173.
  • 2Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD,Mongin SJ, Cordes JE, Engelhard D. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst 2004; 96:770-780.
  • 3Kornek GV, Depisch D, Rosen HR, Temsch EM, Scheithauer W.Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies. J Cancer Res Clin Oncol 1992; 118:318-320.
  • 4Posner MR, Mayer RJ. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am 1994; 8:533-553.
  • 5Ohuchi N, Takahashi K, Matoba N, Sato T, Taira Y, Sakai N,Masuda M, Mori S. Comparison of serum assays for TAG-72,CA19-9 and CEA in gastrointestinal carcinoma patients. Jpn J Clin Oncol 1989; 19:242-250.
  • 6Ueda T, Shimada E, Urakawa T. The clinicopathologic features of serum CA 19-9-positive colorectal cancers. Surg Today 1994; 24:518-525.
  • 7Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A,Yamaguchi H, Yasutake T, Ayabe H, Arisawa K. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients. Hepatogastroenterology 2003; 50:696-699.
  • 8Srinivas PR, Srivastava S, Hanash S, Wright GL Jr. Proteomics in early detection of cancer. Clin Chem 2001; 47:1901-1912.
  • 9Hurlstone DP, Fujii T, Lobo AJ. Early detection of colorectal cancer using high-magnification chromoscopic colonoscopy.Br J Surg 2002; 89:272-282.
  • 10Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.

共引文献29

同被引文献36

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部